Nexchain presale 2025 is in Stage 27 at $0.108 with a $0.30 listing, offering 278% ROI before exchange trading.
Exclusive: Merck and Wellcome are investing a further £56m into an innovative lab designing cheap vaccines for low-income ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback